BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 28557822)

  • 1. Gut Microbiota and the Gut-Brain Axis: New Insights in the Pathophysiology of Metabolic Syndrome.
    de Clercq NC; Frissen MN; Groen AK; Nieuwdorp M
    Psychosom Med; 2017 Oct; 79(8):874-879. PubMed ID: 28557822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota, metabolism and psychopathology: A critical review and novel perspectives.
    Groen RN; de Clercq NC; Nieuwdorp M; Hoenders HJR; Groen AK
    Crit Rev Clin Lab Sci; 2018 Jun; 55(4):283-293. PubMed ID: 29673295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota.
    Bauer PV; Hamr SC; Duca FA
    Cell Mol Life Sci; 2016 Feb; 73(4):737-55. PubMed ID: 26542800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota-Dependent Modulation of Energy Metabolism.
    Heiss CN; Olofsson LE
    J Innate Immun; 2018; 10(3):163-171. PubMed ID: 29131106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome.
    de Cossío LF; Fourrier C; Sauvant J; Everard A; Capuron L; Cani PD; Layé S; Castanon N
    Brain Behav Immun; 2017 Aug; 64():33-49. PubMed ID: 28027925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the gut microbiota on inflammation, obesity, and metabolic disease.
    Boulangé CL; Neves AL; Chilloux J; Nicholson JK; Dumas ME
    Genome Med; 2016 Apr; 8(1):42. PubMed ID: 27098727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders.
    Rajani C; Jia W
    Clin Sci (Lond); 2018 Apr; 132(7):791-811. PubMed ID: 29661926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy.
    Kang Y; Cai Y
    Hormones (Athens); 2017 Jul; 16(3):223-234. PubMed ID: 29278509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents.
    Ejtahed HS; Soroush AR; Angoorani P; Larijani B; Hasani-Ranjbar S
    Horm Metab Res; 2016 Jun; 48(6):349-58. PubMed ID: 27203411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microbiota-gut-brain axis in obesity.
    Torres-Fuentes C; Schellekens H; Dinan TG; Cryan JF
    Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):747-756. PubMed ID: 28844808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kynurenine pathway metabolism and the microbiota-gut-brain axis.
    Kennedy PJ; Cryan JF; Dinan TG; Clarke G
    Neuropharmacology; 2017 Jan; 112(Pt B):399-412. PubMed ID: 27392632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut-Brain Axis and Behavior.
    Martin CR; Mayer EA
    Nestle Nutr Inst Workshop Ser; 2017; 88():45-53. PubMed ID: 28346923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and metabolic syndrome.
    Wang PX; Deng XR; Zhang CH; Yuan HJ
    Chin Med J (Engl); 2020 Apr; 133(7):808-816. PubMed ID: 32106124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota and the gut-brain axis.
    Bienenstock J; Kunze W; Forsythe P
    Nutr Rev; 2015 Aug; 73 Suppl 1():28-31. PubMed ID: 26175487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications.
    Osadchiy V; Martin CR; Mayer EA
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):322-332. PubMed ID: 30292888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of Gastrointestinal Glucose Homeostasis by the Gut-Brain Axis.
    Chen X; Eslamfam S; Fang L; Qiao S; Ma X
    Curr Protein Pept Sci; 2017; 18(6):541-547. PubMed ID: 27356933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbes and the mind: emerging hallmarks of the gut microbiota-brain axis.
    Bauer KC; Huus KE; Finlay BB
    Cell Microbiol; 2016 May; 18(5):632-44. PubMed ID: 26918908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases.
    Konturek PC; Haziri D; Brzozowski T; Hess T; Heyman S; Kwiecien S; Konturek SJ; Koziel J
    J Physiol Pharmacol; 2015 Aug; 66(4):483-91. PubMed ID: 26348073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.